(Q51117753)

30 March 2018

title

The central hyperglycaemic effect of clonidine (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

4 January 2024

1 reference

J. U. Bock

1

1 reference

PubMed ID

5132556

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5132556

4 January 2024

P. A. van Zwieten

2

1 reference

PubMed ID

5132556

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5132556

4 January 2024

language of work or name

English

0 references

publication date

1 November 1971

1 reference

30 March 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0014299971900318?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

https://api.elsevier.com/content/article/PII:0014299971900318?httpAccept=text/plain

4 January 2024

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

European Journal of Pharmacology

4 January 2024

published in

1 reference

30 March 2018

volume

16

1 reference

30 March 2018

issue

3

1 reference

30 March 2018

page(s)

303-310

1 reference

30 March 2018

Evidence for a central noradrenaline receptor stimulation by clonidine.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

A study of factors controlling activity of neurons within the paraventricular, supraoptic and ventromedian nuclei of the hypothalamus

4 January 2024

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Effect of high spinal cord section on epinephrine hyperglycemia

4 January 2024

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Hyperglycaemia induced by drugs

4 January 2024

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Central hypotensive effect of alpha-methyldopa.

4 January 2024

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

The distribution of carotid and vertebral blood in the brain of the cat.

4 January 2024

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

The centrally induced fall in blood pressure after the infusion of amphetamine and related drugs into the vertebral artery of the cat

4 January 2024

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Hyperglycemic action of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride in relation to its hypertensive effect

4 January 2024

15

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Effects of Clonidine on central sympathetic tone.

4 January 2024

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Propranolol uptake into the central nervous system and the effect on rat behaviour and amine metabolism.

4 January 2024

18

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Cardiovascular effects of prostaglandins mediated by the central nervous system of the dog

4 January 2024

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Hyperglycemia induced by the action of adrenalia on the central nervous system

4 January 2024

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Some effects of propranolol on the central nervous system

4 January 2024

21

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

The Pharmacologic Effects of ST-155 (Catapres) and Related Imidazolines in the Rat

4 January 2024

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Central effects of clonidine (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, St 155) upon thermoregulation in the sheep and goat.

4 January 2024

23

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

A central nervous system component of epinephrine hyperglycemia.

4 January 2024

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Acute hypotensive action of 2-(2,6-dichlorophenylamino)- 2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery

4 January 2024

27

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan)

4 January 2024

28

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan) and alpha-adrenergic blocking drugs.

4 January 2024

29

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane

4 January 2024

30

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

Reciprocal influences of the ventromedial and lateral hypothalamic nuclei on blood glucose level and liver glycogen content.

4 January 2024

32

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

[On a new hypertensive agent with predominant central action, 2-(2,6-dichlorophenylamino)-2-imidazolinhydrochloride (St 155)]

4 January 2024

35

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90031-8

4 January 2024

Identifiers

1 reference

30 March 2018

PubMed ID

5132556

1 reference

30 March 2018